-
1
-
-
0032522873
-
Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies
-
Lazarou, J.; Pomeranz, B. H.; Corey, P. N. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. J. Amer. Med. Assoc. 1998, 279, 1200-1205.
-
(1998)
J. Amer. Med. Assoc.
, vol.279
, pp. 1200-1205
-
-
Lazarou, J.1
Pomeranz, B.H.2
Corey, P.N.3
-
2
-
-
0033624575
-
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
-
Altshuler, D.; et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 2000, 26 (1), 76-80.
-
(2000)
Nat. Genet.
, vol.26
, Issue.1
, pp. 76-80
-
-
Altshuler, D.1
-
3
-
-
0033863391
-
SNPing away at complex diseases: Analysis of single-nucleotide polymorphisms around APOE in Alzheimer's disease
-
Martin, E. R; et al. SNPing away at complex diseases: Analysis of single-nucleotide polymorphisms around APOE in Alzheimer's disease. Am. J. Hum. Genet. 2000, 67 (2), 383-394.
-
(2000)
Am. J. Hum. Genet.
, vol.67
, Issue.2
, pp. 383-394
-
-
Martin, E.R.1
-
4
-
-
0004120124
-
-
Oxford University Press: New York
-
Weber, W. W. Pharmacogenomics; Oxford University Press: New York, 1997.
-
(1997)
Pharmacogenomics
-
-
Weber, W.W.1
-
5
-
-
0032231751
-
Pharmacogenetics of cancer therapy: Getting personal
-
Krynetski, E. Y.; Evans, W. E. Pharmacogenetics of cancer therapy: Getting personal. Am. J. Hum. Genet. 1998, 63, 11-16.
-
(1998)
Am. J. Hum. Genet.
, vol.63
, pp. 11-16
-
-
Krynetski, E.Y.1
Evans, W.E.2
-
6
-
-
0032544336
-
Genetic variation as a guide to drug development
-
Kleyn, P. W.; Vesell, E. S. Genetic variation as a guide to drug development Science 1998, 281, 1820-1821.
-
(1998)
Science
, vol.281
, pp. 1820-1821
-
-
Kleyn, P.W.1
Vesell, E.S.2
-
7
-
-
0033606540
-
Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial
-
Durant, J.; et al. Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial. Lancet 1999, 353, 2195-2199.
-
(1999)
Lancet
, vol.353
, pp. 2195-2199
-
-
Durant, J.1
-
8
-
-
0033769401
-
HIV-1 drug resistance genotyping. A review of clinical and economic issues
-
Chaix-Couturier, C.; et al. HIV-1 drug resistance genotyping. A review of clinical and economic issues. Pharmacoeconomics 2000, 18 (5), 425-433.
-
(2000)
Pharmacoeconomics
, vol.18
, Issue.5
, pp. 425-433
-
-
Chaix-Couturier, C.1
-
9
-
-
0033059209
-
Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
-
Drazen, J. M.; et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment Nat. Genet. 1999, 22, 168-170.
-
(1999)
Nat. Genet.
, vol.22
, pp. 168-170
-
-
Drazen, J.M.1
-
10
-
-
0032495541
-
The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis
-
Kuivenhoven, J. A.; et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N. Engl. J. Med. 1998, 338, 86-93.
-
(1998)
N. Engl. J. Med.
, vol.338
, pp. 86-93
-
-
Kuivenhoven, J.A.1
-
11
-
-
0035869407
-
Use of chemotherapy plus a monoclonal antibody against Her2 for metastatic breast cancer that overexpresses Her2
-
Slamon, D. J.; et al. Use of chemotherapy plus a monoclonal antibody against Her2 for metastatic breast cancer that overexpresses Her2. N. Engl. J. Med. 2001, 344, 783-792.
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 783-792
-
-
Slamon, D.J.1
-
12
-
-
0035865322
-
A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
-
Sachidanandam, R.; et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001, 409 (6822), 928-933.
-
(2001)
Nature
, vol.409
, Issue.6822
, pp. 928-933
-
-
Sachidanandam, R.1
|